A population-based study exploring racial and gender inequities in polysubstance-related deaths across the United States from 2004 to 2022

Joinpoint regression was used to examine mortality rates for opioid-only, opioids with a stimulant, opioids with benzodiazepines, among racial/gender groups to measure temporal trends in age-adjusted overdose mortality due to polysubstance-related overdose.